Meeting
2023 ASCO Annual Meeting
ctDNA detection in patients with brain metastases arising from solid tumors.
Authors
Laura Alder
Duke University Medical Center, Durham, NC
Laura Alder , Gloria Broadwater , Michelle Green , Eric S. Lipp , Amanda E.D. Van Swearingen , Jeffrey Melson Clarke , Carey K. Anders , Sarah Sammons
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2027)
DOI
10.1200/JCO.2023.41.16_suppl.2027
Abstract #
2027
Poster Bd #
384
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Targeted ctDNA sequencing analysis reveals concurrent genomic alterations and its impact on TKI and immune checkpoint inhibitor therapy in advanced NSCLC from Asian population.
First Author: Wei Wu
Poster
2017 ASCO Annual Meeting
Simultaneous molecular alterations in solid tumors with IDH1 or IDH2 mutations.
First Author: Filip Janku
Poster
2024 ASCO Annual Meeting
Characterization of diverse targetable ERBB2 alterations in 512,993 patients with solid tumors.
First Author: Dazhi Liu
Poster
2023 ASCO Annual Meeting
Investigating racial inequities of circulating tumor DNA (ctDNA) use in patients with non-small cell lung cancer: A real world analysis.
First Author: Angelica D'Aiello